By Adriano Marchese

 

Canadian eye-care product provider Bausch + Lomb Corp. said Tuesday that its over-the-counter eye drop product has been approved by Canada's health regulator.

The company, which was spun out of Bausch Health Cos. earlier in the month, said Health Canada has approved Lumify, also known as brimonidine tartrate ophthalmic solution, a treatment for redness of the eye.

Bausch + Lomb said the product will be available at pharmacy retailers in Canada by July.

Lumify was approved by the U.S. Food and Drug Administration in 2017.

 

Write to Adriano Marchese at adriano.marchese@wsj.com

 

(END) Dow Jones Newswires

May 24, 2022 07:47 ET (11:47 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Bausch and Lomb (TSX:BLCO)
Historical Stock Chart
From Jun 2022 to Jul 2022 Click Here for more Bausch and Lomb Charts.
Bausch and Lomb (TSX:BLCO)
Historical Stock Chart
From Jul 2021 to Jul 2022 Click Here for more Bausch and Lomb Charts.